DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
CancerWorld Issue #110 (December) is Live
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
25 Posts Not to Miss from ASH 2025
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
